Ditch, just wondering how reliable your source is re Esensor Sales.
OMH management have said that esensor sales have been controlled to date,
'The manufacturing scale-up process and product performance have been satisfactory throughout this critical initial sales period and the Directors are confident that the Group will be able to expand sales moving into next year as the installed base of instruments increases.'
suggesting to me that the new year should bring a leap in Esensor Sales.
Optigene sales are expected to commence early 2007, and interest in the Optitube is high.
My take on it all is that OMH management would not have sold the CC Division if signs were not good that the Molecular Diagnostics Divisions is beginning to shine!!!!
Osmetech stock quotes
Osmetech stock charts
Follow this thread
